Sunshine Heart: a Takeover Bid Just a Heartbeat Away?

The last company I featured as a takeover prospect was a telecommunications play now trading at 7 month highs, 40% higher from where I profiled it less than a month ago. Today I focus my attention on a small medical device company that I believe will be pursued by a major player in the industry at many multiples of its current price. The name of this company is Sunshine Heart (SSH). The leaders in the medical device industry have recently been implicated in major setbacks with respect to their cardiac devices that seriously threaten to stunt their growth in the foreseeable future. Meanwhile, Sunshine Heart, an early-stage company that makes a less invasive device in this multi-billion dollar market, has had a landmark year, achieving a number of highly significant milestones. The market has been richly rewarding companies that engage in strategic acquisitions, as I will detail below. Sunshine Heart is an ideal fit for one of the big players in the industry, and the cheapest in the space. Based on the recent flurry of M&A in the sector, the insanely low valuation of Sunshine Heart, and the recent setbacks of other companies in the sector, I fully expect one of the big players to swoop in and offer to purchase Sunshine Heart at a hefty premium.

Back to news